ClinicalTrials.gg
Drug

Ambroxol clinical trials

studies test it
21
open now
6
in phase 3
5
first study started
2005

How each study uses Ambroxol is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Ambroxol studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Ambroxol
12
Ambroxol Hydrochloride
8
Mucosolvan
3
Mucosolvon
2

Brand

Lasolvan®
1

Studies by the year they started

21 studies that test it; most in 2023 (4)

Studies that test Ambroxol, by start year
YearStudies
20051
20071
20112
20122
20151
20161
20181
20191
20211
20222
20234
20241
20253

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
14
Phase 3
5
Phase 4
1
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 7 · Other 14

Boehringer Ingelheim (3) · London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (2) · Agyany Pharma LTD (2) · University College, London (2) · Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta (1) · National University of Malaysia (1) · Shaare Zedek Medical Center (1) · Hull University Teaching Hospitals NHS Trust (1)

Often tested with

Tested in the same studies.

Dipropizine (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test Ambroxol.

Studies

Open first, then newest update. How each study uses Ambroxol is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 21

See all 21 studies that test Ambroxol →

Given beside what is tested · 1 — Ambroxol is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with Ambroxol

What changed recently

From the registry's own updates since Oct 17, 2026.

Stopped1

Codes

What other systems call Ambroxol · ClinicalTrials.gg INT006938

  • MeSH (NLM) D000551AmbroxolConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 200168S0CLAMBROXOLConfirmed FDA, NLM, Wikidata
  • RxNorm 625Confirmed FDA, Wikidata
  • Wikidata Q221637ambroxolConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C74262AmbroxolOne source FDA
  • DrugBank DB06742One source Wikidata

Also registered as ambroxol hydrochloride (UNII CC995ZMV90 · RxNorm 438399).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.